念珠菌尿路感染的治疗现状  

Current Status of Treatment for Candida Urinary Tract Infections

作　　者：包美荣 赵建平 

机构地区：[1]内蒙古医科大学内蒙古临床医学院,内蒙古 呼和浩特 [2]内蒙古自治区人民医院检验科,内蒙古 呼和浩特

出　　处：《临床医学进展》2024年第11期900-905,共6页Advances in Clinical Medicine

摘　　要：尿路感染是临床常见感染性疾病之一,常见病原微生物有细菌、真菌、病毒、支原体、衣原体、滴虫、原虫等。近年来,由于广谱抗生素、免疫抑制剂和激素等药物的广泛应用,目前,真菌性尿路感染的比重逐日升高,主要以念珠菌感染为主。本文将为读者提供一个有关念珠菌尿路感染治疗方面的综述,旨在为临床预防以及治疗念珠菌尿路感染提供新的诊治思路。Urinary tract infection is one of the common infectious diseases in clinic. The common pathogenic microorganisms include bacteria, fungi, viruses, mycoplasmas, chlamydia, trichomonas, protozoa, etc. In recent years, due to the widespread use of broad-spectrum antibiotics, immunosuppressants, and hormones, the proportion of fungal urinary tract infections has been increasing day by day, mainly caused by Candida infections. This article will provide readers with a review on the treatment of Candida urinary tract infections, offering new diagnostic and therapeutic approaches for clinical prevention and treatment of Candida urinary tract infections.

关 键 词：尿路感染 念珠菌 氟康唑 棘白菌素类抗菌药物 两性霉素B 

分 类 号：R44[医药卫生—诊断学]